Science-Focused Conference on Cannabis Therapeutics Offers Plenty for MMJ Professionals
The upcoming Seventh National Clinical Conference on Cannabis Therapeutics in Arizona might sound a bit dry to the average professional in the medical marijuana industry.
Just take a look at the lineup of science-focused sessions, which feature titles such as “Overview of the Endocannabinoid System,” “Empirical Rationales for the Possibility of Cannabis Therapeutics in Post Traumatic Stress,” and “Phytocannabinoids in the Treatment of Breast Cancer and Glioma Cell Cancer.” Speakers include doctors, researchers, nonprofit heads and executives of health care companies from across the United States and as far away as Israel.
But don’t let the health focus deter you from attending: There’s plenty of benefits for dispensary owners, vendors and other involved more in the business side of medical cannabis.
For starters, the conference will provide a solid overview of how cannabis is used as medicine for many different ailments, giving MMJ professionals a better understanding of the industry – and the product it revolves around – in general. As Robert Kane – who publishes an investment-focused newsletter about medical marijuana and provides consulting to cannabis companies – puts it: “How can you be part of the medical industry if you don’t have an understanding of the medicine?”
The conference also offers a great networking and business opportunity for entrepreneurs looking to get into the industry and current players, as many movers and shakers in medical cannabis will be on hand (an estimated 350 people are expected to attend). Fellow MMJ lawyers, doctors who write cannabis prescriptions, investors, patients and advocates are expected to be in the crowd.
There will also be vendor booths for organizations and companies to spread the word about their services and products.
The conference will held from April 26 to 28 at the Loews Ventana Canyon in Tuscon, Arizona. Registration costs $315 for professionals and $215 for the general public. This year’s focus is on the emerging science of the endogenous cannabinoid system (ECS), with the aim of helpping clinicians “understand how and why cannabis is safe and effective for such a wide variety of health problems.”
Sponsors of the event include Patients Out of Time, the University of California – San Francisco School of Medicine and the University of Arizona College of Nursing.
For more information or to register, visit this link – (note: the site was not loading correctly at the time of this posting).
The formerly fractured Arizona marijuana community emerged as a united front on Friday, with representatives [click to continue...]
Medical marijuana programs in two states are looking for new leaders. Bob Morgan, the coordinator [click to continue...]
A pair of proposed 2016 ballot measures tied to cannabis have been filed with the [click to continue...]
CNN’s chief medical correspondent Sanjay Gupta gave the medical marijuana industry another shot in the [click to continue...]
Two California lawyers have teamed up to start the National Cannabis Bar Association, with the [click to continue...]
Marijuana businesses hoping for some potential legal guidance on unionization from a case in New [click to continue...]
A federal judge in California on Wednesday declined to overturn marijuana’s place on the Drug [click to continue...]
Washington State Gov. Jay Inslee will likely sign a bill passed by the Legislature that [click to continue...]
Some attorneys still won’t touch the cannabis industry, it seems. David Knowlton, co-founder of the [click to continue...]
The opening of Delaware’s first and only MMJ dispensary has been delayed again, but this [click to continue...]
Even though New York hasn’t even begun issuing business licenses yet for medical marijuana companies, [click to continue...]
In response to attempts by lawmakers to extend the timeline for the state’s medical cannabis [click to continue...]
Banks have filed more than 1,700 so-called “marijuana limited” suspicious activity reports since the federal [click to continue...]
Arizona dispensaries could see fewer new patients after the state’s governor signed a bill forcing [click to continue...]